A global centre for cancer research and treatment based in south London is a step closer to becoming a reality after Sutton councillors endorsed plans for its development in the borough.
Sutton Council’s Housing, Economy and Business Committee has approved the Development Framework for The London Cancer Hub, which aims ultimately to become the world’s leading life-science campus specialising in cancer research, treatment, education and enterprise.
The London Cancer Hub is a partnership between the London Borough of Sutton and The Institute for Cancer Research, London, with supporting partners The Royal Marsden NHS Foundation Trust, the Greater London Authority and Epsom and St Helier University Hospitals NHS Trust.
Caption: This plan illustrates how The London Cancer Hub could look in 20 years time. The site is well connected and easy to move around. There exists a well-integrated mix of academic, business and clinical activities. Within the site there are several new focal points where neighbourhood amenities are located.
Sutton Council’s Housing, Economy and Business Committee has approved the Development Framework for The London Cancer Hub, which aims ultimately to become the world’s leading life-science campus specialising in cancer research, treatment, education and enterprise.
The London Cancer Hub is a partnership between the London Borough of Sutton and The Institute for Cancer Research, London, with supporting partners The Royal Marsden NHS Foundation Trust, the Greater London Authority and Epsom and St Helier University Hospitals NHS Trust.
Caption: This plan illustrates how The London Cancer Hub could look in 20 years time. The site is well connected and easy to move around. There exists a well-integrated mix of academic, business and clinical activities. Within the site there are several new focal points where neighbourhood amenities are located.
The London Cancer Hub Development Framework sets out the vision for a world-leading life-science campus that will bring together scientists, clinicians and innovative commercial enterprises. It will be a hotbed for talent, offering research and development space for biotech, pharma, and software and technology companies. It will be located on the Sutton site of The Institute of Cancer Research (ICR) and The Royal Marsden in Belmont and Epsom and St Helier’s hospital in Sutton.
The total transformation of the site will see inward investment in excess of £1bn over the lifetime of the project. More than 13,000 new jobs are expected to be created in Sutton – 7,000 life-science, clinical and support staff, and another 6,200 in the site’s construction.
Sutton Council also plans to build a new free school on the site, providing secondary education for up to 1,275 students who will benefit from being part of the life-science campus.
The London Cancer Hub will double the space available for world-class cancer research and deliver a wide range of state-of-the-art scientific facilities. It will also substantially increase the rate of discovery of new treatments and their availability for cancer patients.
It is hoped that the London Cancer Hub will bring further public transport investment into Sutton through the creation of an integrated transport system that extends the Tramlink from Wimbledon to Sutton Station via Morden and onwards to the Belmont site.
The London Cancer Hub will form one of three outstanding life-science districts within London. As such, it will be one of the most significant regeneration projects in London and will require the co-ordination of public institutions and private partners.
Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:
“It’s really exciting to see our plans for The London Cancer Hub take shape, and I’m delighted that the Development Framework for the site has now been approved by Sutton Council. This will be a truly world-class centre for cancer research, treatment and innovation, and its impacts will be felt across the UK and globally, but especially here in Sutton.”
Daniel Elkeles, Chief Executive of Epsom and St Helier University Hospitals NHS Trust, said:
“We are delighted to be part of such an exciting opportunity. It has the potential to completely transform how we deliver healthcare to the communities we serve.”
Jeremy Skinner, Senior Manager, Growth and Enterprise at the Greater London Authority, said:
“The London Cancer Hub represents a unique opportunity in cancer research and treatment. By working with the NHS and the Institute of Cancer Research, the London Borough of Sutton will not only transform of 26 hectares of brownfield site into a significant life sciences cluster and a truly international ‘innovation hub’, but also bring about significant economic growth in the region.
“It will help contribute to London’s leading position in innovative life sciences cancer research, complementing assets such as the recently opened Francis Crick Institute. The Greater London Authority has been supportive of this project from its inception, providing design expertise and challenge and contributing to its business case development. We hope that it will continue to develop and progress towards delivery.”
cancer
.
FVH10
The total transformation of the site will see inward investment in excess of £1bn over the lifetime of the project. More than 13,000 new jobs are expected to be created in Sutton – 7,000 life-science, clinical and support staff, and another 6,200 in the site’s construction.
Sutton Council also plans to build a new free school on the site, providing secondary education for up to 1,275 students who will benefit from being part of the life-science campus.
The London Cancer Hub will double the space available for world-class cancer research and deliver a wide range of state-of-the-art scientific facilities. It will also substantially increase the rate of discovery of new treatments and their availability for cancer patients.
It is hoped that the London Cancer Hub will bring further public transport investment into Sutton through the creation of an integrated transport system that extends the Tramlink from Wimbledon to Sutton Station via Morden and onwards to the Belmont site.
The London Cancer Hub will form one of three outstanding life-science districts within London. As such, it will be one of the most significant regeneration projects in London and will require the co-ordination of public institutions and private partners.
Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:
“It’s really exciting to see our plans for The London Cancer Hub take shape, and I’m delighted that the Development Framework for the site has now been approved by Sutton Council. This will be a truly world-class centre for cancer research, treatment and innovation, and its impacts will be felt across the UK and globally, but especially here in Sutton.”
Daniel Elkeles, Chief Executive of Epsom and St Helier University Hospitals NHS Trust, said:
“We are delighted to be part of such an exciting opportunity. It has the potential to completely transform how we deliver healthcare to the communities we serve.”
Jeremy Skinner, Senior Manager, Growth and Enterprise at the Greater London Authority, said:
“The London Cancer Hub represents a unique opportunity in cancer research and treatment. By working with the NHS and the Institute of Cancer Research, the London Borough of Sutton will not only transform of 26 hectares of brownfield site into a significant life sciences cluster and a truly international ‘innovation hub’, but also bring about significant economic growth in the region.
“It will help contribute to London’s leading position in innovative life sciences cancer research, complementing assets such as the recently opened Francis Crick Institute. The Greater London Authority has been supportive of this project from its inception, providing design expertise and challenge and contributing to its business case development. We hope that it will continue to develop and progress towards delivery.”
cancer
.
FVH10